OPPORTUNITIES FOR BIOTECH RESEARCH AND DEVELOPMENT IN AFRICA: ISSUES AND OPTIONS

OPPORTUNITIES FOR BIOTECH RESEARCH AND DEVELOPMENT IN AFRICA: ISSUES AND OPTIONS PowerPoint PPT Presentation


  • 102 Views
  • Uploaded on
  • Presentation posted in: General

INTRODUCTION. The 8th AU summit held in Addis Ababa, Ethiopia, in January, 2007, endorsed the development of a 20-year African Biotechnology Strategy with specific regional technology goals, and to develop and harmonize national and regional regulations that promote the application and safe use of modern biotechnology. This initiative should help to realize the MDGs of halving the number of poor and hungry people by 2015.

Download Presentation

OPPORTUNITIES FOR BIOTECH RESEARCH AND DEVELOPMENT IN AFRICA: ISSUES AND OPTIONS

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


1. OPPORTUNITIES FOR BIOTECH RESEARCH AND DEVELOPMENT IN AFRICA: ISSUES AND OPTIONS UN ECA, Addis Ababa, Ethiopia March 2008 Prof. Walter S. Alhassan PBS Coordinator for West Africa FARA/PBS, Accra, Ghana.

2. INTRODUCTION The 8th AU summit held in Addis Ababa, Ethiopia, in January, 2007, endorsed the development of a 20-year African Biotechnology Strategy with specific regional technology goals, and to develop and harmonize national and regional regulations that promote the application and safe use of modern biotechnology. This initiative should help to realize the MDGs of halving the number of poor and hungry people by 2015

3. BENEFITS AND RISKS ASSOCIATED WITH BIOTECH Biotechnology has been defined as a set of tools that uses living organisms (or part of organisms) to make or modify a product, improve plants, trees or animals, or develop microorganisms for specific uses.

4. Biotechnology Tools Tissue culture and micro-propagation Marker Assisted Selection Monoclonal Antibody for Diagnostics Genetic Engineering or Transformation or Recombinant DNA

5. Biotechnology Tools Genetic engineering and GM crops Genetic engineering is a powerful tool that is used to move genes from one species into another by artificial means. The species may or may not be related. Wide species crossing that is possible with genetic engineering (GE) is almost impossible under natural means of hybridization. It raises safety concerns to the environment and human health

7. Benefits from GM technology As lessons of the Green Revolution have shown, its impact depends on three conditions: first, that the technology is relevant to those farmers and affordable; second, that the technology is scale neutral; and third, that the existing socio-economic environment (such as access to markets, information or inputs) is not heavily biased against small-scale farms.

8. Benefits associated with GM technology Plants may be genetically engineered to produce: Own toxins e.g. Bt proteins Herbicide tolerance Drought tolerance Disease resistance Nutrient improvement Efficient nitrogen utilization Powerful diagnostic tools

9. Benefits associated with GM technology Products on the horizon from gene technology that will revolutionize agriculture in Africa for the poor are drought tolerant and nitrogen efficient crops and biofortified crops. An on-going initiative in Africa for biofortification is the biofortified sorghum project financed by the Bill and Melinda Gates Foundation and coordinated by Africa Harvest.

10. Secondary Benefits Reduced carbon emission –zero tillage Water conservation- drought tolerant crops Reduces soil degradation-zero tillage Reduces Nitrogen fertilizer use from nitrogen-efficient crops Enhanced biofuel production Healthier farm labour from reduced pesticide use.

11. PERCEIVED RISKS ASSOCIATED WITH GMOS IN AGRICULTURE: Change in biodiversity from gene flow Human health- toxicity and allergenecity Social implications from the effect on biodiversity; loss of livelihood; perceived dominance from multi-nationals. Mitigating approaches Containment and confinement Genetic manipulation such as chloroplast transformation and GURT or Terminator technology. No Terminator Gene product on the market yet.

12. GLOBAL STATUS OF BIOTECH CROPS: 2007 The phenomenal growth in the cultivation of GM or biotech crops that was noticed in the first decade (1996-2005) continues into the second decade (2006-2015). The 2007 world status of GM crops shows a 12% or 12.3 million hectares in the cultivation of GM crops over the 2006. Currently 114.3 million hectares (James, 2007). The crops grown are roundup ready soybean, Bt maize, Bt cotton and Bt canola. South Africa, the only country in Africa commercializing GM crops in 2007 cultivated 1.8 million hectares of GM crops most of which is white maize used for food and the remainder cotton. All categories of farmers in South Africa grow biotech crops. Burkina Faso is expected to commercialise Bt cotton this year.

13. OPPORTUNITIES FOR BIOTECHNOLOGY RESEARCH AND DEVELOPMENT IN AFRICA Persistent low yield of cereals around 1 mt/ha. Existence of biotic and abiotic stresses. In sub-Sahara Africa, various sub-regional institutions exist that address capacity building in biotechnology and biosafety. Positive pronouncements on biotechnology development.

14. Sub-regional initiatives West Africa CORAF/WECARD ECOWAS The objective of the ECOWAS plan is to establish a regional approach to biotechnology and biosafety. The implementing agent for this on behalf of ECOWAS is the INSAH/CILSS. CILSS/INSAH - the Framework Convention Introducing a Common Biosafety Regulation for the Prevention of Biotechnology Risks, -Framework Convention Instituting Common Regulations for Conventional and Transgenic Seeds and -the Structure and Operation of the Regional Consultative Committee for Seeds and Biosafety.

15. Sub-regional initiatives West Africa West Africa Regional Biosafety Project The objective of the project is to establish a regional capability in biosafety among the francophone economic union in West Africa, the West African Economic and Monetary Union (WAEMU). This is a 4-year $4,500 project to be funded by the Global Environment Facility for the benefit of 5 of the 8 countries forming the WAEMU (www.gefweb.org/documents/council_documents).

16. Sub-regional initiatives East Africa RABESA INITIATIVE The Regional Approach to Biotechnology and Biosafety Policy in Eastern and Southern Africa (RABESA) is a COMESA driven project designed to examine the implications of modern biotechnology on trade, food security and access to emergency food aid. This is a 2-year initiative from 2004 to 2006. It involved six countries- Kenya, Uganda, Tanzania, Ethiopia, Egypt and Zambia. It findings were that with the exception of Egypt which exports about 47 % of GM sensitive commodities to Europe the likely adverse impact of GM crops would be minimal.

17. Sub-regional initiatives East Africa BIO-EARN This is the East Africa Regional Programme and Research Network for Biotechnology, Biosafety and Biotechnology Policy Development (BIOEARN). It operates in Ethiopia, Kenya, Tanzania and Uganda. The capacity building phase (1999-2004) trains high level manpower up to the PhD level in various aspects of biotechnology. The Phase II (2006-2009) is designed to enhance agricultural productivity, clean water production and the reduction of environmental damage all applying biotechnology tools.

18. Sub-regional initiatives Southern Africa FANRPAN (the Food Agriculture Natural Resources Policy Research and Analysis Network) in SADC Region. It has two product lines, namely, agricultural biotechnology and biosafety issues and the improvement of food security in the SADC Region. Pilot or trial countries: Malawi, Mauritius and South Africa

19. Sub-regional initiatives Southern Africa Key Lessons from FANRPAN are that: Most Countries in SADC, except SA, still taking a precautionary approach Need to integrate social scientists into GMO research and promotion – “social marketing” Embrace opposition through multi-stakeholder dialogues that highlight benefits and respond accurately to concerns Policy Briefs for decision makers Strategic partnerships and institutional arrangements - Building credibility and legitimacy through evidence-based research and a robust communication strategy

20. AFRICA WIDE INITIATIVES Manpower Training Initiatives the Rockefeller Foundation Initiative in Capacity Building in Africa MSc and PhD. Molecular Breeding, Conventional Plant Breeding. Focus is East Africa. West Africa Crop Improvement Initiative (WACCI) PhD in conventional Plant Breeding. To be launched on March 11 ’08. Funded by RF and Bill/Melinda Gates Foundation.

21. AFRICA WIDE INITIATIVES FARA ABBI The African Biotechnology and Biosafety Initiative (ABBI) is one of the network support projects of FARA. Will create a forum where various sub-regions can share information and experiences on agricultural biotechnology and biosafety. NEPAD Biosciences Centers A network of bioscience laboratories and expertise in the biosciences has been established in the 4 sub-regions of Africa. Except for the one in Eastern Africa, BECA, these have been newly established and yet to start program implementation.

22. AFRICA WIDE INITIATIVES PBS This is a 5-year capacity building program in biosafety funded by the USAID. It started in 2003. ABSPII This also started in 2003 as a sister project to the PBS. It is designed to build capacity in the introduction of near term biotechnology products or services. Assisted the Uganda black sigatoka resistant GM banana development and field testing and in the tomato YLCV virus control project in Mali and selected WA countries. AATF This is a public-private sector non-profit initiative that facilitates the negotiation and transfer proprietary technologies on a royalty-free basis for the development of agriculture for the benefit of the resource-poor farmers and others in Africa. Bt gene from Monsanto cowpea.

23. LESSONS FROM OTHER DEVELOPING WORLD China: with the exception of some varieties of Bt cotton, all the biotech crops commercialized in China have been developed by Chinese state institutions with public sector funding. Argentina: the rapid adoption of RR-soybean due in part to: -a well-established seed industry, -a regulatory system that provided a responsible timely and cost-effective system for approving biotech products and -a technology with high impact. Brazil: high political will and support for biotechnology. Recent funding equivalent to US$7 billion (60% and 40% private) and prorated at US$700 million per year for the next 10 years has been announced.

24. WAY FORWARD Africa needs to re-double its efforts in the acquisition of the capacity for the judicious utilization of all the tools of modern biotechnology to solve the farming problems of the sub-region. The following holistic arrangements must be harnessed as the way forward: User friendly Biosafety Legislative framework in place, Vigorous training of scientists, technicians and the provision of functional laboratories Enhanced service conditions; Development of a viable seed sector; Credit and input supply facilitation for agriculture;

25. WAY FORWARD market infrastructure development and stimulation of inter-African trade. Increased budgetary allocation to agriculture and rural development; increased south-south and north-south collaboration in science and technology with the emphasis on biotechnology. A country strategically placing itself in the forefront of science and technology cannot afford not to have research programmes in agricultural biotechnology. A country that does otherwise may miss the gene revolution.

26. THANK YOU!!!

  • Login